Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shanghai Shenqi Pharmaceutical Investment Management Co (900904) Fair Value & Analysis

Healthcare · CN · Market cap $228M

Price$0.4220
Fair Value$1.56
Upside+269.7%
Quality92/100
Evidence: High Range $1.17 – $1.95

Fair value as of: Jun 25, 2026

Analysis

Shanghai Shenqi Pharmaceutical Investment Management Co (900904) currently trades at $0.4220, while our model-based Fair Value estimate is $1.56 — implying the stock looks roughly 269.7% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.

Open the full interactive analysis →

Similar stocks

Eli Lilly and Company (LLY) -60% Johnson & Johnson, (JNJ) -32% AbbVie Inc (ABBV) -52% Roche Holding (ROGN) -20% Merck & Co (MRCK34) -82% AstraZeneca PLC (A1ZN34) -85%

Frequently asked questions

Is Shanghai Shenqi Pharmaceutical Investment Management Co (900904) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $1.56 versus a price of $0.4220 — about +270% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 900904?
Our 21-model fair value for Shanghai Shenqi Pharmaceutical Investment Management Co is $1.56 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.4220.
What is the quality score of 900904?
Shanghai Shenqi Pharmaceutical Investment Management Co has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.